Cargando…

Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is implicated in liver cell proliferation. However, its role in hepatic steatosis and insulin resistance remain poorly understood. The aim of this study was to investigate the effects of MALAT1 on hepatic lipid accumulation and its pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Caifeng, Chen, Jinfeng, Chen, Nuoqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776244/ https://www.ncbi.nlm.nih.gov/pubmed/26935028 http://dx.doi.org/10.1038/srep22640

Ejemplares similares

The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
por: Moon, Young-Ah
Publicado: (2017)

Impact of silencing hepatic SREBP-1 on insulin signaling
por: Jideonwo, Victoria, et al.
Publicado: (2018)

GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
por: Yang, Xiaoli, et al.
Publicado: (2017)

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
por: Tang, Kairui, et al.
Publicado: (2020)

Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule
por: Wang, Miao, et al.
Publicado: (2013)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
por: Zhai, Mingming, et al.
Publicado: (2021)

JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism
por: Wei, Qin, et al.
Publicado: (2018)

Induction of long noncoding RNA MALAT1 in hypoxic mice
por: Lelli, Aurelia, et al.
Publicado: (2015)

NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis
por: Guo, Yunwei, et al.
Publicado: (2020)

Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix
por: Brown, Jessica A., et al.
Publicado: (2014)

Structural analysis of MALAT1 long noncoding RNA in cells and in evolution
por: Monroy-Eklund, Anais, et al.
Publicado: (2023)

Redox-Unlockable Nanoparticle-Based MST1 Delivery System to Attenuate Hepatic Steatosis via the AMPK/SREBP-1c Signaling Axis
por: Li, Yuhan, et al.
Publicado: (2022)

The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy
por: Chen, Qingjuan, et al.
Publicado: (2020)

A functional interaction between Hippo‐YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice
por: Shu, Zhiping, et al.
Publicado: (2019)

Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p
por: Yan, Caifeng, et al.
Publicado: (2018)

Long Noncoding RNA MALAT-1 Can Predict Poor Prognosis: A Meta-Analysis
por: Tang, Ruixue, et al.
Publicado: (2016)

O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice
por: Kang, Saeromi, et al.
Publicado: (2021)

Ablation of long noncoding RNA MALAT1 activates antioxidant pathway and alleviates sepsis in mice
por: Chen, Jingshu, et al.
Publicado: (2022)

Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma
por: Xu, Enhong, et al.
Publicado: (2019)

Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction
por: Zhang, Tong, et al.
Publicado: (2022)

Octyl gallate induces hepatic steatosis in HepG2 cells through the regulation of SREBP-1c and PPAR-gamma gene expression
por: Lima, Kelly Goulart, et al.
Publicado: (2020)

Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway
por: Wang, Ling-Fang, et al.
Publicado: (2017)

Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer
por: Eastlack, Steven C., et al.
Publicado: (2018)

Association of long noncoding RNA MALAT1 polymorphisms with gastric cancer risk in Korean individuals
por: Hong, Jang Hee, et al.
Publicado: (2020)

Upregulation of Long Noncoding RNA MALAT1 in Colorectal Cancer Promotes Radioresistance and Aggressive Malignance
por: Shen, Wenqi, et al.
Publicado: (2022)

Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
por: Yang, Nian, et al.
Publicado: (2019)

TAK1 regulates hepatic lipid homeostasis through SREBP
por: Morioka, Sho, et al.
Publicado: (2016)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance
por: Deng, Wei, et al.
Publicado: (2012)

Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
por: Zeng, Tianshu, et al.
Publicado: (2016)

Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
por: Jiao, Feng, et al.
Publicado: (2015)

Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus
por: Yang, Huaxia, et al.
Publicado: (2017)

The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration
por: Zhou, Yanqing, et al.
Publicado: (2016)

The long noncoding RNA Malat1 regulates CD8(+) T cell differentiation by mediating epigenetic repression
por: Kanbar, Jad N., et al.
Publicado: (2022)

Long noncoding RNA MALAT1 sponges miR-129-5p to regulate the development of bronchopulmonary dysplasia by increasing the expression of HMGB1
por: Yangi, Rongwe, et al.
Publicado: (2020)

Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis
por: Sozen, Erdi, et al.
Publicado: (2021)

Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
por: Omanovic Kolaric, Tea, et al.
Publicado: (2022)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism
por: de Lima, R.P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_he02lqfp39aocphs2n575i1ge0